AstraZeneca PLC (OTCMKTS:AZNCF – Get Free Report) was the recipient of a large growth in short interest during the month of March. As of March 31st, there was short interest totalling 67,800 shares, a growth of 15.9% from the March 15th total of 58,500 shares. Based on an average daily volume of 3,300 shares, the short-interest ratio is currently 20.5 days.
AstraZeneca Trading Down 2.1 %
AstraZeneca stock opened at $135.94 on Tuesday. AstraZeneca has a fifty-two week low of $118.16 and a fifty-two week high of $153.10. The firm has a 50 day moving average price of $131.07 and a 200 day moving average price of $130.68.
AstraZeneca Increases Dividend
The business also recently announced a dividend, which was paid on Monday, March 25th. Investors of record on Friday, February 23rd were issued a $1.97 dividend. The ex-dividend date was Wednesday, February 21st. This is an increase from AstraZeneca’s previous dividend of $0.93. AstraZeneca’s dividend payout ratio (DPR) is 343.14%.
About AstraZeneca
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacture, and commercialization of prescription medicines. The company's marketed products include Tagrisso, Imfinzi, Lynparza, Calquence, Enhertu, Orpathys, Truqap, Zoladex, Faslodex, Farxiga, Brilinta, Lokelma, Roxadustat, Andexxa, Crestor, Seloken, Onglyza, Bydureon, Fasenra, Breztri, Symbicort, Saphnelo, Tezspire, Pulmicort, Bevespi, and Daliresp for cardiovascular, renal, metabolism, and oncology.
Featured Stories
- Five stocks we like better than AstraZeneca
- Investing In Preferred Stock vs. Common Stock
- Retail Investors Can Follow Goldman Sachs’ Moves This Quarter
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- Johnson & Johnson is as Cheap as it’s Going to Get
- How to Use the MarketBeat Dividend Calculator
- PayPal’s User Decline Won’t Stop Its Double-Digit Upside
Receive News & Ratings for AstraZeneca Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AstraZeneca and related companies with MarketBeat.com's FREE daily email newsletter.